Richard K. Amewu

ORCID, self-asserted

ORCID 0000-0002-4676-436X

Publications

Citations

119

h-index

Computed over the works the graph holds, so it is a floor rather than a career figure.

i10-index

Publications

24 works in the graph, newest first.

Biological Targets in Leishmaniasis and the Identification of the Next Generation of Antileishmanial Compounds
2026Current Drug TherapyJournalSenior authorCorresponding0 citations10.2174/0115748855407118251114095002
Identification of Compound 15 (MMV1581361) as a Pf ATP4 Inhibitor with Transmission-Blocking Activity and In Vivo Efficacy in a SCID Mouse Model of Malaria
2026Journal of Medicinal ChemistryJournalSenior authorCorresponding0 citations10.1021/acs.jmedchem.5c01954
Isolation and synthesis of bioactive molecules against Schistosoma mansoni from Boscia senegalensis (Pers) Lam. ex Poir. (Capparaceae) bark extracts used in West African traditional medicine
2026Scientific AfricanJournalOpen access0 citations10.1016/j.sciaf.2026.e03309
Redefining the geography of pharmaceutical innovation: Kelly Chibale as a harbinger for integrated drug discovery in Africa
2026Frontiers in Drug DiscoveryJournalOpen access0 citations10.3389/fddsv.2026.1884834
Therapeutic Potential of Natural Products as Innovative and New Frontiers for Combating Parasitic Diseases
2025ParasitologiaJournalOpen accessCorresponding6 citations10.3390/parasitologia5030049
Application of Hosomi-Sakurai allylation reaction in total synthesis of biologically active natural products
2025Frontiers in ChemistryJournalOpen accessSenior authorCorresponding4 citations10.3389/fchem.2025.1527387
Collaborative Synthesis for Neglected Diseases through the Open Synthesis Network: Structure–Activity Relationships of Arylaminopyrazoles as Chagas Disease Treatments
2025ACS Infectious DiseasesJournalOpen access2 citations10.1021/acsinfecdis.5c00481
Characterization of a chromen-based anticancer agent using computer-aided drug discovery reveals selective interaction with EGFR and VEGFR2
2025In Silico Research in BiomedicineJournalOpen accessCorresponding1 citations10.1016/j.insi.2025.100137
A novel chromen-based small molecule induces apoptosis and modulates cellular response to triple-negative breast cancer
2025Scientific ReportsJournalOpen access1 citations10.1038/s41598-025-16195-y
Design and Synthesis of Arylboronic Acid Chemosensors for the Fluorescent-Thin Layer Chromatography (f-TLC) Detection of Mycolactone
2025ChemosensorsJournalOpen accessSenior authorCorresponding0 citations10.3390/chemosensors13070244
Molecular docking, design, synthesis and in vitro analysis identify [1,2,4]triazolo[4,3-b]pyridazine derivatives as inhibitors of Leishmania donovani sterol methyltransferase
2025Journal of Parasitic DiseasesJournalSenior authorCorresponding0 citations10.1007/s12639-025-01849-5
Pharmacological properties and molecular interaction analysis of three small molecules reveal selective interaction with the Epidermal Growth Factor Receptor
2025Zenodo (CERN European Organization for Nuclear Research)JournalOpen access0 citations10.5281/zenodo.17652607
Sustainably addressing Africa’s antimicrobial pollution crisis
2024Nature Reviews Earth & EnvironmentJournal4 citations10.1038/s43017-024-00618-x
Exploring Mycolactone—The Unique Causative Toxin of Buruli Ulcer: Biosynthetic, Synthetic Pathways, Biomarker for Diagnosis, and Therapeutic Potential
2024ToxinsJournalOpen accessSenior authorCorresponding3 citations10.3390/toxins16120528
Inhibiting Leishmania donovani Sterol Methyltransferase to Identify Lead Compounds Using Molecular Modelling
2023PharmaceuticalsJournalOpen accessSenior authorCorresponding18 citations10.3390/ph16030330
Targeting Leishmania donovani sterol methyltransferase for leads using pharmacophore modeling and computational molecular mechanics studies
2023Informatics in Medicine UnlockedJournalOpen accessCorresponding8 citations10.1016/j.imu.2023.101162
Alternative boronic acids in the detection of Mycolactone A/B using the thin layer chromatography (f-TLC) method for diagnosis of Buruli ulcer
2023BMC Infectious DiseasesJournalOpen accessSenior authorCorresponding5 citations10.1186/s12879-023-08426-2
Versatile Structurally Diverse Natural Products and Their Semisynthetic Analogs as Potential Antileishmanial Drugs
2023Book Chapter0 citations10.1007/978-981-19-9605-4_17
Homology Modeling, de Novo Design of Ligands, and Molecular Docking Identify Potential Inhibitors of Leishmania donovani 24-Sterol Methyltransferase
2022Frontiers in Cellular and Infection MicrobiologyJournalOpen access18 citations10.3389/fcimb.2022.859981
Drug discovery research in Ghana, challenges, current efforts, and the way forward
2022PLoS neglected tropical diseasesJournalOpen accessFirst authorCorresponding16 citations10.1371/journal.pntd.0010645
Targeting the Ubiquinol-Reduction (Qi) Site of the Mitochondrial Cytochrome bc1 Complex for the Development of Next Generation Quinolone Antimalarials
2022BiologyJournalOpen access17 citations10.3390/biology11081109
Evaluation of the fluorescent-thin layer chromatography (f-TLC) for the diagnosis of Buruli ulcer disease in Ghana
2022PLoS ONEJournalOpen accessFirst authorCorresponding10 citations10.1371/journal.pone.0270235
Synthesis and initial testing of novel antimalarial and antitubercular isonicotinohydrazides
2022Results in ChemistryJournalOpen accessFirst authorCorresponding5 citations10.1016/j.rechem.2022.100287
Integrated Management Strategies (Diagnosis, Treatment, and Wound Care Management) for Improved Clinical Outcomes of Buruli Ulcer in Ghana: A Retrospective Case Report in the Ga West Municipal Hospital, Amasaman
2022Clinical Medical Reviews and Case ReportsJournalOpen accessSenior author1 citations10.23937/2378-3656/1410379